| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/24/2007 | US7208598 Trans-N2-(4-aminocyclohexyl)-N6-[2-[[[4-choro-3-trifluoromethyl)-phenyl]-methyl]-amino]-ethyl]-9-cyclopentyl-9H-purin-2,6-diamine trihydrochloride; cycline-dependent kinase proteins (cdk) inhibitor; animitotic, antitumor agents |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/24/2007 | US7208508 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 04/24/2007 | US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/24/2007 | US7208501 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | US7208495 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208469 Administering adrenomedullin for stimulate chondrocyte proliferation; treatment of cartilage defects, bone disorders, growth disorders; biodrugs |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208291 Protein comprising cytoplasmic domain, membrane-spanning domain and an extracellular domain with biotin-binding activity; avidin activity; endocytosis |
| 04/24/2007 | US7208283 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208162 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 04/24/2007 | US7208147 Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity |
| 04/24/2007 | CA2410852C 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinic receptor antagonists |
| 04/24/2007 | CA2407763C Para-amine substituted phenylamide glucokinase activators |
| 04/24/2007 | CA2303763C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 04/24/2007 | CA2289574C 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/24/2007 | CA2289472C Excitatory amino acid receptor modulators |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2281471C Process for preparing eprosartan |
| 04/24/2007 | CA2234610C New amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic |
| 04/24/2007 | CA2171934C Endothelin receptor antagonists |
| 04/24/2007 | CA2167171C A method of protecting against neuron loss |
| 04/24/2007 | CA2159776C Imidobisphosphoric acids, process for their preparation, and use thereof |
| 04/24/2007 | CA2141951C Inhibition of retrovirus infection |
| 04/24/2007 | CA2131644C Quinoline compounds |
| 04/19/2007 | WO2007043653A1 Benzimidazole-5-carboxamide derivative |
| 04/19/2007 | WO2007043652A1 2-thienylurea derivative |
| 04/19/2007 | WO2007043640A1 Substance for use in treatment or prevention of hcv infection |
| 04/19/2007 | WO2007043630A1 Nkt cell-stimulating agent for administration through upper respiratory tract mucous membrane |
| 04/19/2007 | WO2007043629A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | WO2007043568A1 S1p3 receptor antagonist |
| 04/19/2007 | WO2007043457A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | WO2007043433A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 04/19/2007 | WO2007043426A1 Dermatitis remedies |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043365A1 Therapeutic agent for neurogenic pain |
| 04/19/2007 | WO2007043363A1 Composition for use in prevention of hypoglycemic condition |
| 04/19/2007 | WO2007042272A2 Use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 04/19/2007 | WO2007041775A1 Cysteine protease inhibitors incorporating azide groups |
| 04/19/2007 | WO2007041773A1 Sumoylation control agent and uses thereof |
| 04/19/2007 | WO2006125616A3 Pyrimidine-based cdk inhibitors for treating pain |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 04/19/2007 | US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects; |
| 04/19/2007 | US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
| 04/19/2007 | US20070088044 Quinazoline derivatives as antitumor agents |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | US20070088020 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/19/2007 | US20070087958 Compounds and compositions for delivering active agents |
| 04/19/2007 | US20070087416 Hyaluronan synthase gene and uses thereof |
| 04/19/2007 | US20070087037 Stimulation of cpt-1 as a means to reduce weight |
| 04/19/2007 | US20070086993 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 04/19/2007 | US20070086984 Viruses for the Treatment of Cellular Proliferative Disorders |
| 04/19/2007 | US20070086956 Method for accelerating the rate of mucociliary clearance |
| 04/19/2007 | DE10212564B4 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne 1-allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine |
| 04/19/2007 | CA2626011A1 S1p3 receptor antagonist |
| 04/19/2007 | CA2624909A1 Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease |
| 04/19/2007 | CA2624683A1 Modulators of atp-binding cassette transporters |
| 04/19/2007 | CA2623563A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
| 04/18/2007 | EP1775341A1 Method of inducing the differentiation of amnion-origin cells and utilization of the same |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/18/2007 | EP1775297A2 Adenosine receptor antagonists and methods of making and using the same |
| 04/18/2007 | EP1775289A1 Novel imidazolidine derivatives |
| 04/18/2007 | EP1775286A1 Novel anandamide amidase inhibitors as analgesic agents |
| 04/18/2007 | EP1773988A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/18/2007 | EP1773349A2 Methods and compositions for treatment of preeclampsia |
| 04/18/2007 | EP1773324A1 Porphyrin derivatives and their use in photon activation therapy |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/18/2007 | EP1406893B1 Pyrrolidine bicyclic compounds |
| 04/18/2007 | EP1394161B1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 04/18/2007 | EP1393727B1 Remedial agent for myelopathic disease |
| 04/18/2007 | EP1392313B1 Combination comprising n- 5- 4-(4-methyl-piperazino-methyl)-benzoylamido|-2-methylphenyl -4-(3-pyridyl)-2pyrimidine-amine and a biphosphonate |
| 04/18/2007 | EP1354590B1 Glucosamine or mannosamine in combination with trehalose against articular failure |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1343525B1 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1326613B2 Use of substituted imidazo 1,2-a|pyridine-, imidazo ¬1,2-a|pyrimidine and imidazo ¬1,2-a|pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2007 | EP1324652B1 Transgenic drosophila melanogaster expressing beta amyloid |
| 04/18/2007 | EP1272642B1 Coffee mannanase |
| 04/18/2007 | EP1227812B1 Topical nasal treatment using desloratadine and mometasone furoate |
| 04/18/2007 | EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/18/2007 | EP1153125B1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use |
| 04/18/2007 | EP1137408B1 Agent for lowering endothelin levels |